Íñigo Valiente-Alandí

Author

Cincinnati Children's Hospital Medical Center

Also Known As

Inigo Valiente-Alandi, Iñigo Valiente-Alandi, Iñigo Valiente‐Alandi, Íñigo Valiente-Alandí

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Cincinnati Children's Hospital Medical Center University of Cincinnati Spanish National Centre for Cardiovascular Research Louisiana State University Health Sciences Center Shreveport Centro Nacional de Biotecnología

ÍV

About

Íñigo Valiente-Alandí is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, cell biology, and cardiac regeneration.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	710
2	Cell Biology	3	3	710
3	Cardiac Regeneration	2	2	690
4	Pharmacology	1	1	62
5	Regenerative Medicine	1	1	628

Íñigo Valiente-Alandí

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart Xing Fu, Hadi Khalil, Onur Kanisicak, Journal of Clinical Investigation Cardiac MuscleCardiac Progenitor CellsCardiac RegenerationRegenerative MedicineTissue Development	2018	628
Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure Íñigo Valiente-Alandí, Sarah J. Potter, Ane Salvador, Circulation	2018	259
DoubletDecon: Deconvoluting Doublets from Single-Cell RNA-Sequencing Data Erica A. K. DePasquale, Daniel Schnell, Pieter-Jan Van Camp, Cell Reports	2019	195
cellHarmony: cell-level matching and holistic comparison of single-cell transcriptomes Erica A. K. DePasquale, Daniel Schnell, Phillip J. Dexheimer, Nucleic Acids Research	2019	74
A specialized population of Periostin-expressing cardiac fibroblasts contributes to postnatal cardiomyocyte maturation and innervation Luis Hortells, Íñigo Valiente-Alandí, Zachary M. Thomas, Proceedings of the National Academy of Sciences	2020	69
Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression Joshua G. Travers, Fadia Kamal, Íñigo Valiente-Alandí, Journal of the American College of Cardiology Molecular PharmacologyFibrosisHeart FailureCardiovascular DiseaseCell Signaling	2017	62
Myofibroblast-Specific TGFβ Receptor II Signaling in the Fibrotic Response to Cardiac Myosin Binding Protein C-Induced Cardiomyopathy Qinghang Meng, Bidur Bhandary, Md. Shenuarin Bhuiyan, Circulation Research	2018	51
Bmi1 + cardiac progenitor cells contribute to myocardial repair following acute injury Íñigo Valiente-Alandí, Carmen Albo-Castellanos, Diego Herrero, Stem Cell Research & Therapy	2016	43
Cardiac Bmi1 + cells contribute to myocardial renewal in the murine adult heart Íñigo Valiente-Alandí, Carmen Albo-Castellanos, Diego Herrero, Stem Cell Research & Therapy	2015	41
Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF‐β Signaling Bidur Bhandary, Qinghang Meng, J. Howard James, Journal of the American Heart Association	2018	41

Page 1